Evaluation of the Navitor Valve for Aortic Stenosis
Official title: VISTA Nova Study (Navitor Post-Market Clinical Follow Up Study)
Run by Abbott Medical Devices · NCT06008080 · Data updated 2026-11-12
This study tests how well the Navitor heart valve works and how safe it is for people with aortic stenosis in everyday situations.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Abbott Medical Devices Industry-sponsored |
| Locations | 50 sites (Adelaide and 49 other locations) |
| Status | Recruiting |
| Started | September 29, 2023 |
| Main results expected | July 2027 |
| Study ends | June 2032 |
| Registry record updated | July 10, 2026 |
| Trial ID | NCT06008080 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients diagnosed with aortic stenosis who are eligible for the Navitor TAVI procedure and can commit to follow-up visits.
✕Probably not a fit
Patients who are not eligible for the Navitor TAVI System or have a life expectancy of less than 12 months due to non-cardiac conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the safety and performance of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System in patients with aortic stenosis in a real-world setting. It aims to assess the long-term durability of the valve and gather data on its effectiveness post-implantation. Patients will be monitored through follow-up visits to ensure comprehensive data collection and analysis of outcomes.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term safety and effectiveness of the Navitor valve, potentially improving treatment options for patients with aortic stenosis.
How similar studies have gone: Other studies evaluating TAVI systems have shown promising results, indicating that this approach is supported by previous successful research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient is eligible per the current approved indication after Heart Team discussion and intended to undergo a Navitor TAVI procedure. * The patient has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent as approved by the IRB (Investigational Review Board)/EC (Ethics Committee) of the respective clinical site. * The patient and the treating physician agree that the subject will return for all required post procedure follow up visits. Exclusion Criteria: * Patient is not eligible for the Navitor TAVI System per the current Instructions for Use (IFU) * Life expectancy \< 12 months from the time of informed consent due to non-cardiac co-morbid conditions. * In the judgment of the Investigator, patient presents with a medical, social, or psychological condition that could limit the ability or willingness to participate in the study, comply with study required testing and/or follow-up visits or that could impact scientific integrity of the study. * Known contraindication for computed tomography (CT) or sensitivity to contrast media, which cannot be adequately premedicated. * Inability to tolerate antiplatelet/anticoagulation therapy or nitinol alloy (nickel and titanium), which cannot be adequately premedicated. * Currently participating in an investigational drug or device study that may confound the results of this study * Anatomy that makes insertion and endovascular access to the aortic valve difficult and/or impossible
Where it's running
-
Royal Adelaide Hospital
Adelaide, Australia Recruiting -
Royal Hobart Hospital
Hobart, Australia Recruiting -
The Alfred Hospital
Melbourne, Australia Recruiting -
Institute Cardio. Paris-Sud - Institut Jacques Cartier
Massy, France Recruiting -
Clinique du Millénaire
Montpellier, France Recruiting -
Mutualiste Montsouris
Paris, France Recruiting
Show 44 more locations
-
CHRU Hopital de Pontchaillou
Rennes, France Recruiting -
CHU Pointchaillou Rennes
Rennes, France Recruiting -
Clinique Pasteur Toulouse
Toulouse, France Recruiting -
Herz- u. Gefäßzentrum Bad Bevensen
Bad Bevensen, Germany Recruiting -
Medizinische Einrichtungen der Universität zu Köln
Cologne, Germany Recruiting -
St Johannes Hospital Dortmund
Dortmund, Germany Recruiting -
Kliniken der Friedrich-Alexander-Universitat
Erlangen, Germany Recruiting -
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
Frankfurt, Germany Recruiting -
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Kiel, Germany Recruiting -
Deutsches Herzzentrum München des Freistaates Bayern
München, Germany Recruiting -
Universitätsklinikum Ulm
Ulm, Germany Recruiting -
Sheba Medical Center
Tel HaShomer, Israel Recruiting -
Az. Osp. Spedali Civili di Brescia
Brescia, Italy Recruiting -
Casa di Cura Pineta Grande
Castel Volturno, Italy Recruiting -
Centro Cardiologico Monzino
Milan, Italy Recruiting -
Ospedale San Raffaele - Cardiac
Milan, Italy Recruiting -
IRCCS ISMETT - Palermo
Palermo, Italy Recruiting -
Policlinico Universitario A. Gemelli
Roma, Italy Recruiting -
Policlinico San Donato
San Donato Milanese, Italy Recruiting -
Ospedale Umberto I di Torino
Torino, Italy Recruiting -
Onze Lieve Vrouw Gasthuis
Amsterdam, Netherlands Recruiting -
Leiden University Medical Center
Leiden, Netherlands Recruiting -
UMC Utrecht
Utrecht, Netherlands Recruiting -
ULS de Lisboa Ocidental
Carnaxide, Portugal Recruiting -
ULS de São José
Lisbon, Portugal Recruiting -
Hospital Clinic de Barcelona
Barcelona, Spain Recruiting -
Hospital de la Santa Creu I Sant Pau
Barcelona, Spain Recruiting -
Hospital General Juan Ramon Jimenez
Huelva, Spain Recruiting -
Hospital de Gran Canaria Doctor Negrín
Las Palmas, Spain Recruiting -
Hospital Universitario Puerta de Hierro
Majadahonda, Spain Recruiting -
HCU Virgen de la Victoria
Málaga, Spain Recruiting -
Consorcio Hospital General Universitario de Valencia
Valencia, Spain Recruiting -
Sahlgrenska University Hospital - Gothenburg
Gothenburg, Sweden Recruiting -
KS St. Gallen / USZ
Sankt Gallen, Switzerland Recruiting -
Kings College Hospital
London, United Kingdom Recruiting -
St. Thomas Hospital
London, United Kingdom Recruiting -
Royal Stoke University Hospital
Stoke-on-Trent, United Kingdom Recruiting -
New Cross Hospital
Wolverhampton, United Kingdom Recruiting -
Deutsches Herzzentrum der Charité
Berlin, Germany Active not recruiting -
UKE Hamburg
Hamburg, Germany Active not recruiting -
University Hospital Rostock
Rostock, Germany Active not recruiting -
Hospital Universitario de Badajoz
Badajoz, Spain Active not recruiting -
James Cook University Hospital
Middlesbrough, United Kingdom Active not recruiting -
Royal Stoke University Hospital
Stoke-on-Trent, United Kingdom Active not recruiting
Study contacts
- Principal investigator: Alper Öner, MD — Universitätsmedizin Rostock, Germany
- Study coordinator: Bart Janssens
- Email: bart.janssens@abbott.com
- Phone: +32471723201
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exercise and nutrition support before and after TAVI for older adults with aortic stenosis
This trial tests whether a personalized exercise program plus protein and iron supplements before and after a transcatheter valve replacement can help older adults with aortic stenosis recover better than standard care.
-
Association Between Aortic Valve Area Changes and Pulmonary Congestion After TAVI
This study tests whether improvements in aortic valve opening after TAVI relate to reductions in lung congestion measured by ultrasound in adults with severe aortic stenosis.
-
Systematic 14-day ambulatory heart monitoring after TAVI
After TAVI, patients with certain heart conduction abnormalities will try 14 days of wearable ECG monitoring to see if it lowers the chances of sudden death, symptomatic heart rhythm problems, or stroke within a year compared to standard follow-up.
-
Echo-AVCS: Drawing AI-powered clues from heart scans to confirm severe aortic stenosis
This study tests an AI-based echocardiography score to help confirm severe aortic stenosis in adults who are also getting CT calcium scoring.
-
TAVI without on-site heart surgery: can selected centers do it safely?
This trial tests whether transcatheter aortic valve implantation can be done safely in certain hospitals that don’t have on-site cardiac surgery, for patients with severe aortic stenosis who are appropriately selected.
-
Willem AI for early detection of aortic stenosis from a 12‑lead ECG
This project will test whether the Willem AI can detect aortic stenosis from routine 12‑lead ECGs in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.